The development of modern medicine is a story stretching back thousands of years, a testament to humanity's persistent efforts to alleviate suffering. From the earliest settlements to the sophisticated research laboratories of today, the quest for effective treatments has evolved dramatically.
Archaeological findings at sites like Skara Brae, a Neolithic village in Orkney, reveal the ancient use of medicinal plants. Historical records further illuminate this long-standing practice. Cuneiform tablets from 7th century BCE Mesopotamia detail nearly 5,000 medical prescriptions, while the ancient Egyptian Ebers papyrus is considered one of the earliest comprehensive texts on treating diseases with plants. Ancient Greece and Rome also produced their own medical writings.
Some historical remedies, however, appear peculiar by modern standards. Roman texts suggested burning weasels and using the ashes to treat gout, and Egyptians advocated for hippopotamus dung to address gastrointestinal issues. In fact, animal feces were widely considered beneficial for centuries; a 1618 London pharmacopoeia listed eleven types of therapeutic excrement.
The Dawn of Scientific Pharmacology
The 18th century marked a significant shift toward a more scientific approach to medicine. Dr. William Withering of Birmingham identified the active compound in foxgloves, a discovery that revolutionized the treatment of congestive heart failure. Concurrently, James Lind conducted what is recognized as an early clinical trial, demonstrating that citrus consumption could prevent scurvy among sailors.
Today, pharmacology, the study of how medicines function and impact the body, is a robust academic field and a global industry. In the UK alone, over a billion prescriptions are issued annually, while the United States sees six times that number.
The Modern Pharmaceutical Landscape
While the pharmaceutical industry, often referred to as "Big Pharma," sometimes faces public scrutiny, the development of potentially life-saving drugs involves immense investment in time, effort, and resources. The success rate for new drugs is remarkably low, with approximately 95% failing, often before human trials even begin.
Clinical trials have also undergone significant improvements. Historically, research often centered on a default "white male body." However, contemporary drug development now emphasizes the importance of diversity in trials, acknowledging that women and various ethnic groups have distinct physiological responses and disease susceptibilities. For instance, certain ethnic groups have higher incidences of specific genetic disorders, and some populations may experience different reactions to medications, such as anti-diabetic drugs. This recognition underscores the need to tailor treatments to individual recipients.
Rod Flower's book offers an accessible exploration of this historical and scientific journey, detailing humanity's ongoing efforts to understand and improve drug therapies.